Overview

Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
1. Clinical Objective : To improve the growth of these children 2. Genetic objective : A study of the genetics of the syndrome
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Hormones